Source: United Press International
Posted: October 19, 2006
Summary:
In a new study, Novocell, a biotechology company in the field of stem cell research, determined the necessary conditions for turning human embryonic stem cells into insulin-producing cells, a finding that moves the prospect of using these cells to treat diabetes closer to the clinic. In the study, the researchers developed a process for differentiating human embryonic stem cells into insulin-producing pancreatic endocrine cells. The technique, which mimics the normal development that occurs in the body, could be used for generating insulin-producing cells that could be transplanted into type 1 diabetes patients. The company estimates human clinical trials could begin in 2 to 3 years.
Commentary: This finding seems to significant advancement in developing stem cell treatments for diabetes in humans.
No comments:
Post a Comment